Abstract
To verify if the entity of the peak GH responses to the GHRH+arginine (ARG) test is able to show different degree forms of GH deficiency (GHD), we linked these responses with the number of other anterior pituitary deficits. These anterior pituitary deficits were also related with IGF-I levels. To this purpose, we studied a large cohort of lean patients with pituitary disease of different etiologies [86 males and 68 females; age: mean±SEM 41.5±1.2 yr, body mass index (BMI) <25 kg/m2]. The patients were subdivided into 4 groups according to the increasing number of hormone deficiencies: isolated GHD (HYPO1, no.=28) or GHD plus one, two or three additional hormones (gonadotrophin, ACTH, and TSH) deficiencies (HYPO2, no.=20; HYPO3, no.=15; HYPO4, no.=91). Peak GH responses to the GHRH+ARG test and IGF-I levels showed a clear difference among the groups (p<0.01 and p<0.001, respectively). A significant difference was found between HYPO1 and HYPO4 for IGF-I levels (p<0.05), and between HYPO1 and HYPO4 and between HYPO2 and HYPO4 for the GHRH+ARG test (p<0.005). Considering only the patients who underwent both GHRH+ARG test and insulin tolerance test (ITT) (no.=70), the pattern of the peak GH responses to the GHRH+ARG test was the same of the whole group of patients, while no statistical difference was found with ITT. Our data show that the peak GH responses to the GHRH+ARG test and the IGF-I levels are linked to the severity of hypopituitarism, expressed by the number of increasing anterior pituitary deficits. This association is lost if the evaluation of the GH status is performed by the ITT. In all, the GHRH+ARG test and measurement of IGF-I are able to evidence different degrees of GHD in adult patients with pituitary disease.
Similar content being viewed by others
References
Rosen T, Bengtsson BA. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990, 336: 285–8.
De Boer H, Blok G, van Der Veen EA. Clinical aspects of growth hormone deficiency in adults. Endocr Rev 1995, 16: 63–86.
Toogood AA, Beardwell GS, Shalet SM. The severity of growth hormone deficiency in adults with pituitary disease is related to the degree of hypopituitarism. Clin Endocrinol (Oxf) 1994, 41: 511–6.
Hoffman DM, O’Sullivan AJ, Baxter RC, Ho KY. Diagnosis of growth hormone deficiency in adults. Lancet 1994, 343: 1064–8.
Thorner MO, Bengtsson BA, Ho KKY, et al. Diagnosis of growth hormone deficiency in adults. J Clin Endocrinol Metab 1995, 80: 3097–8.
Growth Hormone Research Society (GRS). Consensus guidelines for the diagnosis and treatment of adults with GH deficiency. Statement of the GRS workshop on adult GHD. J Clin Endocrinol Metab 1998, 83: 379–81.
Shalet SM, Toogood A, Rahim A, Brennan BM. The diagnosis of growth hormone deficiency in children and adults. Endoc Rev 1998, 19: 203–23.
Ghigo E, Aimaretti G, Arvat E, Camanni F. Growth hormone-releasing hormone combined with arginine or growth hormone secretagogues for the diagnosis of growth hormone deficiency in adults. Endocr Rev 2001, 15: 29–38.
Hoeck HC, Vestergaard P, Jakobsen PE, Laurberg P. Test of growth hormone secretion in adults: poor reproducibility of the insulin tolerance test. Eur J Endocrinol 1995, 133: 305–12.
Vestergaard P, Hoeck HC, Jakobsen E, Laurbarg P. Reproducibility of growth hormone and cortisol responses to the insulin tolerance test and the short ACTH test in normal adults. Horm Metab Res 1997, 29: 106–10.
Jones SL, Trainer PJ, Perry L, Wass JAH, Besser GM, Grossman A. An audit of the insulin tolerance test in adult subjects in an acute investigation unit over one year. Clin Endocrinol (Oxf) 1994, 41: 123–8.
Hoeck HC, Vestergaard P, Jacobsen PE, Falhof J, Laurberg P. Diagnosis of growth hormone (GH) deficiency in adults with hypothalamic-pituitary disorders: comparison of test results using pyridostigmine plus GH-releasing hormone (GHRH), clonidine plus GHRH, and insulin-induced hypoglycemia as GH secretagogues. J Clin Endocrinol Metab 2000, 85: 1467–72.
Aimaretti G, Baffoni C, Di Vito L, et al. Comparison among old and new provocative tests of GH secretion in 178 normal adults. Eur J Endocrinol 2000, 142: 347–52.
Vance ML, Borges JLC, Kaiser DL, et al. Human pancreatic tumor growth hormone-releasing factor (hp GRF-40): dose-response relationship in normal man. J Clin Endocrinol Metab 1984, 58: 838–45.
Aimaretti G, Corneli G, Razzore P, et al. Usefulness of IGF-I assay for the diagnosis of GH deficency in adults. J Endocrinol Invest 1998, 21: 506–11.
Aimaretti G, Corneli G, Razzore P, et al. Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone+arginine as provocative tests for the diagnosis of GH deficiency in adults. J Clin Endocrinol Metab 1998, 83: 1615–8.
Biller BM, Samuels MH, Zagar A, et al. Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. J Clin Endocrinol Metab 2002, 87: 2067–79.
Maccario M, Valetto MR, Savio P, et al. Maximal secretory capacity of somatotrope cells in obesity: comparison with GH deficiency. Int J Obes Relat Metab Disord 1997, 21: 27–32.
Maccario M, Gauba C, Procopio M, et al. Assestment of GH/ IGF-I axis in obesity by evaluation of IGF-I levels and the GH response to GHRH+Arginine test. J Endocrinol Invest 1999, 22: 424–9.
Toogood A, Shalet SM. Diagnosis of growth hormone deficiency in adults. In: Bengtsson BA, Monson JP eds. GH replacement in adults: the first 5 years of KIMS. Oxford: Pharma Genesis TM LTD. 2000.
Hartman ML, Crowe BJ, Biller BM, et al. Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency? J Clin Endocrinol Metab 2002, 87: 477–85.
Lamberts SWJ, de Herder WW, van der Lely AJ. Pituitary insufficiency. Lancet 1998, 352: 127–34.
Thorner MO, Vance ML, Laws Jr ER, Horvath E, Kovacs K. The Anterior pituitary. In: Wilson JD, Foster DW, Kronenberg HM, Reed Larsen P eds. Williams Textbook of Endocrinology. 9th ed. Philadelphia: W.B. Saunders Company. 1998, 165.
Lissett CA, Shalet SM. Hypopituitarism. In: De Groot LJ, Jameson JL eds. Endocrinology. 4th ed. W.B. Philadelphia: Saunders Company. 2001, 198–210.
Faglia G. Clinical Aspects of the pituitary gland. In: Pinchera A ed. Endocrinology and Metabolism. London: McGraw-Hill Int. 2001, 239–51.
Colao A, Di Somma C, Pivonello R, et al. Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism. J Clin Endocrinol Metab 1999, 84: 1919–24.
Colao A, Cerbone G, Pivonello R, et al. The growth hormone (GH) response to the arginine plus GH-releasing hormone test is correlated to the severity of lipid profile abnormalities in adult patients with GH deficiency. J Clin Endocrinol Metab 1999, 84: 1277–82.
Ranke MB. Growth hormone therapy in children: when to stop? Horm Res 1995, 43: 122–5.
Zadik Z, Zung A, Sarel R, Cooper M. Growth of short children during and after discontinuation of growth hormone therapy. J Clin Endocrinol Metab 1996, 81: 3668–70.
Vahl N, Juul A, Jorgensen JO, Orskov H, Skakkebaek NE, Cristiansen JS. Continuation of growth hormone (GH) replacement in GH-deficient patients during transition from childhood to adulthood: a two-year placebo-controlled study. J Clin Endocrinol Metab 2000, 85: 1874–81.
Growth Hormone Research Society. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: Summary statement of the GH Research Society. J Clin Endocrinol Metab 2000, 85: 3993–3.
Svensson J, Johannsson G, Bengtsson BA. Insulin-like growth factor-I in growth hormone-deficient adults: relationship to populaion-based normal value, body composition and insulin tolerance test. Clinical Endocrinology (Oxf) 1997, 46: 579–86.
Marzullo P, Di Somma C, Pratt KL, et al. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults. J Clin Endocrinol Metab 2001, 86: 3001–8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Aimaretti, G., Corneli, G., Di Somma, C. et al. Different degrees of GH deficiency evidenced by GHRH+arginine test and IGF-I levels in adults with pituritary disease. J Endocrinol Invest 28, 247–252 (2005). https://doi.org/10.1007/BF03345381
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03345381